The Impact of Preclinical High Potent P2Y
P2Y12 inhibitor loading
STEMI
acute coronary syndrome
cardiovascular mortality
prasugrel
re-PCI
ticagrelor
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
16 Jun 2023
16 Jun 2023
Historique:
received:
07
05
2023
revised:
09
06
2023
accepted:
13
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Purinergic signaling receptor Y Within this population-based prospective observational study, all patients with ACS who received medical care via the Emergency Medical Service (EMS) in the city of Vienna between January 2018 and October 2020 were enrolled. Patients were stratified according to their P2Y The entire study cohort consisted of 1176 individuals with ST-elevation myocardial infarction (STEMI), of whom 47.5% received prasugrel and 52.5% ticagrelor. The likelihood of adhering to the initial P2Y We observed that, regardless of the initial antiplatelet inhibitor strategy, the in-hospital P2Y
Sections du résumé
BACKGROUND
BACKGROUND
Purinergic signaling receptor Y
METHODS
METHODS
Within this population-based prospective observational study, all patients with ACS who received medical care via the Emergency Medical Service (EMS) in the city of Vienna between January 2018 and October 2020 were enrolled. Patients were stratified according to their P2Y
RESULTS
RESULTS
The entire study cohort consisted of 1176 individuals with ST-elevation myocardial infarction (STEMI), of whom 47.5% received prasugrel and 52.5% ticagrelor. The likelihood of adhering to the initial P2Y
CONCLUSION
CONCLUSIONS
We observed that, regardless of the initial antiplatelet inhibitor strategy, the in-hospital P2Y
Identifiants
pubmed: 37373788
pii: jcm12124094
doi: 10.3390/jcm12124094
pmc: PMC10299011
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2009 Sep 10;361(11):1045-57
pubmed: 19717846
Eur Heart J. 2011 Dec;32(23):2945-53
pubmed: 21804104
Eur Heart J. 2018 Jan 14;39(3):213-260
pubmed: 28886622
Clin Cardiol. 2019 Mar;42(3):391-399
pubmed: 30697776
Lancet. 2009 Feb 28;373(9665):723-31
pubmed: 19249633
N Engl J Med. 2019 Oct 17;381(16):1524-1534
pubmed: 31475799
Circulation. 2010 Nov 23;122(21):2131-41
pubmed: 21060072
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
J Am Coll Cardiol. 2021 Jul 20;78(3):292-294
pubmed: 34266583
N Engl J Med. 2007 Nov 15;357(20):2001-15
pubmed: 17982182
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
Eur Heart J Cardiovasc Pharmacother. 2021 Mar 15;7(2):94-103
pubmed: 31965164